Diabetes treatment is constantly advancing, with new therapeutic options developing to improve patient outcomes. Recent investigations have focused on GLP-1 and GIP receptor agonists, a category of drugs that mimic https://gregoryfsbs658690.wikicommunication.com/5870198/novel_glp_1_and_gip_receptor_agonists_a_new_era_in_diabetes_treatment